Skip to content

Effect of continuous intake of trigonelline in coffee beans on energy metabolism

Effect of continuous intake of trigonelline in coffee beans on energy metabolism :Placebo-controlled, double-blind, randomized, parallel-group comparative study - Effect of continuous intake of trigonelline in coffee beans on energy metabolism :Placebo-controlled, double-blind, randomized, parallel-group comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053244
Enrollment
66
Registered
2024-01-04
Start date
2024-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Subjects of men and women aged 20 to 29 (2)Subjects with a BMI greater than or equal to 23 and less than 30 (3)Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing

Exclusion criteria

Exclusion criteria: (1) Subjects with heart, liver, and kidney diseases (including complications of other diseases) (2) Subjects with a history of cardiovascular disease (3) Subjects with diabetes (4) Subjects with diseases currently being treated (5) Subjects who are allergic to food and drugs (6) Subjects with anemia symptoms (7) Subjects who go to the hospital for some illness or are treated with drugs and Chinese medicine (temporary administration is possible) (8) Subjects who play intense sports and subjects who are on a diet (9) Subjects with extremely irregular eating habits (10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (11) Subjects who drink more than 20 g of average daily pure alcohol (12) Subjects who have a smoking habit (13) Subjects who have participated in other clinical trials within 4 weeks from the start of this study, and subjects who are participating in or will participate in other clinical trials at the start of this study (14) Women who donated 400 ml of blood within 16 weeks before the start of intake, men who donated 400 ml blood within 12 weeks before the start of intake, subjects who donated 200 ml blood within 4 weeks before the start of intake, or donated component blood within 2 weeks (15) Other subjects judged by the investigator or the investigator to be inappropriate for the examination

Design outcomes

Primary

MeasureTime frame
resting energy expenditure

Secondary

MeasureTime frame
brown fat density respiratory quotient body fat mass muscle mass body temperature

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Clinical Trial Division

mterashima@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026